Parallax Volatility Advisers, L.P. Lexicon Pharmaceuticals, Inc. Transaction History

Parallax Volatility Advisers, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.31 - $2.69 $25,237 - $51,822	-19,265 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.95 - $3.89 $31,730 - $63,298	-16,272 Reduced 45.79%	19,265 $40,000
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.16 $135,395 - $218,907	35,537 New	35,537 $140,000
Q3 2021 Nov 15, 2021	SELL	$3.38 - $5.35 $112,665 - $178,331	-33,333 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.12 - $5.87 $137,331 - $195,664	33,333 New	33,333 $153,000
Q2 2019 Aug 14, 2019	SELL	$5.35 - $7.11 $419,381 - $557,345	-78,389 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$4.36 - $7.94 $341,776 - $622,408	78,389 New	78,389 $436,000
Q1 2018 May 15, 2018	SELL	$7.86 - $11.39 $51,168 - $74,148	-6,510 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$8.77 - $12.28 $3.02 Million - $4.23 Million	-344,079 Reduced 98.14%	6,510 $64,000
Q3 2017 Nov 14, 2017	BUY	$12.17 - $16.3 $4.27 Million - $5.71 Million	350,589	350,589 $4.31 Million

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.